Lv5
880 积分 2022-07-25 加入
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice
11天前
已完结
LP2, a cyclic angiotensin-(1−7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
11天前
已完结
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats
18天前
已完结
Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists
28天前
已完结
The Role of Lebrikizumab in the Treatment of Atopic Dermatitis in the Adult Population
1个月前
已关闭
Interleukin-13: A promising therapeutic target for autoimmune disease
1个月前
已完结
The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
1个月前
已完结
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
1个月前
已完结
ADAM10: Function insights, disease implications, and promise of therapeutic targeting
3个月前
已完结
A Minimal Physiologically‐Based Pharmacokinetic Model Demonstrates Role of the Neonatal Fc Receptor (FcRn) Competition in Drug–Disease Interactions With Antibody Therapy
4个月前
已完结
皖公网安备34019202002308
